A
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Akshatha Ganne's research investigates the molecular mechanisms underlying neurodegenerative diseases, with a particular focus on Alzheimer's disease and amyotrophic lateral sclerosis. Her work examines the role of protein aggregates, intrinsically disordered proteins, and their interaction with nucleic acids in disease pathogenesis. Ganne has explored potential therapeutic targets, including glial fibrillary acidic protein as a biomarker and drug target for Alzheimer's disease, and the use of small molecules to rescue lysosomal autophagic failure. She has also investigated the genetic underpinnings of neurodegeneration, such as in silico analysis of TUBA4A mutations in amyotrophic lateral sclerosis. Her research has been published in journals focusing on neuroscience and molecular biology. Ganne has a history of collaboration with researchers at the University of Arkansas for Medical Sciences, including Meenakshisundaram Balasubramaniam, Robert J. Shmookler Reis, and Srinivas Ayyadevara.
Metrics
- h-index: 11
- Publications: 21
- Citations: 283
Selected Publications
-
The aggregate proteome of Caenorhabditis elegans mitochondria implicates shared mechanisms of aging and Alzheimer’s disease (2026)
-
Zolpidem restores sleep and slows Alzheimer’s progression in a mouse model (2025)
-
Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction (2024)
-
Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules (2024)
-
Alzheimer’s-specific brain amyloid interactome: Neural-network analysis of intra-aggregate crosslinking identifies novel drug targets (2023)
-
Myocardial infarction elevates endoplasmic reticulum stress and protein aggregation in heart as well as brain (2023)
-
Protein homeostasis in the aged and diseased heart (2023)
-
In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration (2023)
-
Physiological Consequences of Targeting 14-3-3 and Its Interacting Partners in Neurodegenerative Diseases (2022)
-
Machine-learning analysis of intrinsically disordered proteins identifies key factors that contribute to neurodegeneration-related aggregation (2022)
-
Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer’s Disease (2022)
-
In Silico Analysis of TUBA4A Mutations in Amyotrophic Lateral Sclerosis to Define Mechanisms of Microtubule Disintegration (2022)
-
Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer's Disease (2021)
-
Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration (2021)
-
“Protein aggregates” contain RNA and DNA, entrapped by misfolded proteins but largely rescued by slowing translational elongation (2021)
Collaboration Network
Top Collaborators
Meenakshisundaram Balasubramaniam
University of Arkansas for Medical Sciences
14 shared publications
In database
- Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer’s Disease
- Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration
- “Protein aggregates” contain RNA and DNA, entrapped by misfolded proteins but largely rescued by slowing translational elongation
- Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
- In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration
Showing 5 of 14 shared publications
Robert J. Shmookler Reis
Geriatric Research Education and Clinical Center
12 shared publications
In database
- Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer’s Disease
- Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration
- “Protein aggregates” contain RNA and DNA, entrapped by misfolded proteins but largely rescued by slowing translational elongation
- Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
- In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration
Showing 5 of 12 shared publications
Srinivas Ayyadevara
University of Arkansas at Little Rock
12 shared publications
In database
- Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer’s Disease
- Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration
- “Protein aggregates” contain RNA and DNA, entrapped by misfolded proteins but largely rescued by slowing translational elongation
- Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
- Machine-learning analysis of intrinsically disordered proteins identifies key factors that contribute to neurodegeneration-related aggregation
Showing 5 of 12 shared publications
Nirjal Mainali
Institute on Aging
5 shared publications
In database
- Myocardial infarction elevates endoplasmic reticulum stress and protein aggregation in heart as well as brain
- Physiological Consequences of Targeting 14-3-3 and Its Interacting Partners in Neurodegenerative Diseases
- Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction
- Alzheimer’s-specific brain amyloid interactome: Neural-network analysis of intra-aggregate crosslinking identifies novel drug targets
- Protein homeostasis in the aged and diseased heart
Ramani Atluri
Institute on Aging
3 shared publications
In database
- “Protein aggregates” contain RNA and DNA, entrapped by misfolded proteins but largely rescued by slowing translational elongation
- Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
- Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction
Haarika Ayyadevara
University of Arkansas at Fayetteville
3 shared publications
In database
- Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
- In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration
- In Silico Analysis of TUBA4A Mutations in Amyotrophic Lateral Sclerosis to Define Mechanisms of Microtubule Disintegration
Sonu Pahal
University of Arkansas at Little Rock
3 shared publications
In database
- Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction
- Alzheimer’s-specific brain amyloid interactome: Neural-network analysis of intra-aggregate crosslinking identifies novel drug targets
- The aggregate proteome of Caenorhabditis elegans mitochondria implicates shared mechanisms of aging and Alzheimer’s disease
W. Sue T. Griffin
Central Arkansas Veterans Healthcare System
2 shared publications
In database
- Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
- Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer's Disease
Lily Kiaei
University of California, Los Angeles (US)
2 shared publications
- In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration
- In Silico Analysis of TUBA4A Mutations in Amyotrophic Lateral Sclerosis to Define Mechanisms of Microtubule Disintegration
Kottayil I. Varughese
University of Arkansas for Medical Sciences (US)
2 shared publications
- In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration
- In Silico Analysis of TUBA4A Mutations in Amyotrophic Lateral Sclerosis to Define Mechanisms of Microtubule Disintegration
Mahmoud Kiaei
Arkansas Department of Agriculture (US)
2 shared publications
- In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration
- In Silico Analysis of TUBA4A Mutations in Amyotrophic Lateral Sclerosis to Define Mechanisms of Microtubule Disintegration
Jawahar L. Mehta
Central Arkansas Veterans Healthcare System
2 shared publications
In database
- Myocardial infarction elevates endoplasmic reticulum stress and protein aggregation in heart as well as brain
- Protein homeostasis in the aged and diseased heart
Jay E. Johnson
University of Arkansas for Medical Sciences (US)
1 shared publication
- “Protein aggregates” contain RNA and DNA, entrapped by misfolded proteins but largely rescued by slowing translational elongation
Robert Joseph Shmookler Reis
Central Arkansas Veterans Healthcare System (US)
1 shared publication
- Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer's Disease
W. Sue T. Griffin
University of Arkansas for Medical Sciences (US)
1 shared publication
- Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer’s Disease
Similar Researchers
Based on overlapping research topics
Srinivas Ayyadevara
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Neurological disorders and treatments
Protein Structure and Dynamics
David Kelley
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Neurological disorders and treatments
Protein Structure and Dynamics
Robert Reis
University of Arkansas for Medical Sciences
Neurological disorders and treatments
Protein Structure and Dynamics
Alzheimer's disease research and treatments
Steven W. Barger
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Neurological disorders and treatments
Alzheimer's disease research and treatments
Nirjal Mainali
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Neurological disorders and treatments
Protein Structure and Dynamics
Michelle Gray
University of Arkansas at Fayetteville
Neuroscience and Neuropharmacology Research
Neurological disorders and treatments
Protein Structure and Dynamics